Application 075317
- Type
- ANDA
- Sponsor
- JUBILANT CADISTA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 1MG BASE | No | No |
| 002 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 2MG BASE | No | No |
| 003 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 5MG BASE | No | No |
| 004 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 10MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075317-001 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 |
| A075317-002 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | |
| A075317-003 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | |
| A075317-004 | TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075317-001 | AB |
| A075317-002 | AB |
| A075317-003 | AB |
| A075317-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-001 | TERAZOSIN HYDROCHLORIDE | EQ 1MG BASE | CAPSULE / ORAL | AB | RS | 2004-12-20 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-002 | TERAZOSIN HYDROCHLORIDE | EQ 2MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-003 | TERAZOSIN HYDROCHLORIDE | EQ 5MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-004 | TERAZOSIN HYDROCHLORIDE | EQ 10MG BASE | CAPSULE / ORAL | AB | 2004-12-20 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A075317-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A075317-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A075317-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A075317-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A075317-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A075317-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A075317-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A075317-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075317-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075317-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075317-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075317-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075317-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075317-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075317-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075317-004 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 458b4a60-b2d6-445a-8638-7fcd07decf66 | 2026-06-30 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | REMEDYREPACK INC. | a3a5901a-6395-4030-a27b-1fb17cd97315 | 2026-05-19 | Warnings, Adverse reactions | 075317 ANDA075317 70518-0074 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | REMEDYREPACK INC. | 242589f0-0c79-4ea1-b900-10bccfec2b82 | 2026-05-19 | Warnings, Adverse reactions | 075317 ANDA075317 70518-0342 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Jubilant Cadista Pharmaceuticals Inc. | 43e92495-2cf2-46dd-a80c-f0c3c88c7b73 | 2026-05-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| TERAZOSIN HYDROCHLORIDE | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 2c42171e-1b44-4d34-b6ca-5b6a94f0e694 | 2026-03-10 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin Hydrochloride | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | d971811c-d327-4e63-808c-8d553ee471e7 | 2026-03-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Coupler LLC | 4614e8cc-c922-4c0f-e063-6394a90a8501 | 2025-12-16 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 3822068f-f160-4493-a207-4d75dad6af73 | 2025-11-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | bb88f0d9-e010-4d4d-8465-bcccce0bef6e | 2025-11-05 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin hydrochloride | TERAZOSIN HYDROCHLORIDE | Preferred Pharmaceuticals, Inc | 9d8fd052-b478-447e-a884-74fcd21275bb | 2025-09-30 | Warnings, Adverse reactions | 075317 ANDA075317 68788-9816 68788-9817 68788-9815 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 521e4aad-c6ec-4410-867f-dd9ecc08d5b2 | 2025-09-04 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Bryant Ranch Prepack | 33699a94-4561-455f-9e5d-48856369aa07 | 2025-09-04 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | AvKARE | a2137488-8554-e84f-e053-2995a90a796c | 2025-07-23 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | AvPAK | 9e7b27a6-cc09-407e-e053-2a95a90a17b3 | 2025-07-02 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | A-S Medication Solutions | 4b195327-10d4-477f-ada2-d62c7f835e6c | 2024-11-07 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 40e5ae44-708a-15a3-e054-00144ff8d46c | 2024-08-14 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 363a6c85-e5e9-4521-9065-37a7c45bb525 | 2024-02-06 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 85e450c2-1bc3-49f4-ac2b-5aeedc154bba | 2024-02-01 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 0574d9ae-04da-4cb2-b124-9d920012c411 | 2023-07-20 | Warnings, Adverse reactions | 075317 ANDA075317 |
| Terazosin | TERAZOSIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2f2db826-182d-4dd1-af97-f874b57b1fb9 | 2023-06-15 | Warnings, Adverse reactions | 075317 ANDA075317 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67296-1264 | Terazosin | Terazosin | RedPharm Drug, Inc. | ANDA | Current |
| 67296-1264 | Terazosin | Terazosin | RedPharm Drug, Inc. | ANDA | Current |
| 67296-1264 | Terazosin | Terazosin | RedPharm Drug, Inc. | ANDA | Current |
| 67544-562 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-562 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-563 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-563 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-564 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-564 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-581 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 67544-581 | Terazosin hydrochloride | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 68788-9815 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals | ANDA | Current |
| 68788-9815 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9815 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9815 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9815 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9816 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals | ANDA | Current |
| 68788-9816 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9816 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9816 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9816 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9817 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals | ANDA | Current |
| 68788-9817 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9817 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9817 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 68788-9817 | Terazosin hydrochloride | Terazosin hydrochloride | Preferred Pharmaceuticals, Inc | ANDA | Current |
| 70518-0074 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0074 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0074 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0074 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0317 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0342 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0342 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0342 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-0342 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-1875 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-1875 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-1875 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70518-3114 | Terazosin | Terazosin Hydrochloride | REMEDYREPACK INC. | ANDA | Current |
| 70934-552 | Terazosin | Terazosin Hydrochloride | Denton Pharma, Inc. dba Northwind Pharmaceuticals | ANDA | Current |
| 71610-478 | Terazosin | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-503 | Terazosin | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-510 | Terazosin | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-546 | Terazosin | Terazosin Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |